Table 1 Patient characteristics

From: A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer

 

No. of patients=41 (100%)

Age

 Median/range

54/39–75

Sex

 Male/female

30/11 (30/27)

Performance status

 0/1

35/6 (85/15)

Dysphagia

 Absent/moderate

7/8 (17/19)

 Severe

26 (63)

Tumor location

 Upper third

4 (10)

 Middle third

17 (41)

 Lower third

20 (49)

Histology

 Adenocarcinoma

13 (32)

 Squamous cell carcinoma

28 (68)

EUS T stage a

 2

11 (27)

 3

25 (62)

 4

3 (7)

EUS N stage a

 0

5 (12)

 1/M1a

30/4 (73/10)

  1. Abbreviation: EUS=oesophageal ultrasound endoscopic.
  2. a A total of 39/41 patients.
Back to article page